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Since the introduction of the concept of the “proteome”
10 years ago, the volume of data collected during a pro-
teomic experiment has dramatically increased. Proteomic
experimental methods have expanded to include multi-
dimensional protein separation, evaluation by mass spec-
trometry, protein identification through tandem mass
spectrometry, and quantitation through multiple reaction
monitoring. In order to characterize these results, diverse
bioinformatics tools have been developed. In the broadest
sense, the goal of these tools is to alleviate the bottleneck
resulting from the volume of data collected.
Bioinformatics has provided significant contributions to
the area of proteomics. One area that has contributed
significantly to the analysis of proteomic data is the
development of common data formats for proteomic mass
spectrometric data, such as mzXML and mzData, and the
recent release of mzML as a joint format [1]. With the
availability of such common data formats, open-source
tools have become not only available, but useful to a wide
audience. Availability and utility of data repositories has
provided greater accessibility to data during both publica-
tion review as well as providing additional data for
comparison in subsequent data analysis. The value of these
repositories will only increase as additional data is
deposited over time.
While bioinformatics tools have contributed to the
common research goals, several significant hurdles remain
in proteomics where bioinformatics could offer help. As an
example, even with the recent advances in sample process-
ing and instrumentation technologies, reproducibility of
experimental data remains an issue that hinders meaningful
interpretation of the results. Bioinformatics tools that
incorporate knowledge of the physical process of proteomic
data collection to improve protein identification, quantita-
tion, and data normalization would be very valuable in
studies involving differential analysis of protein expres-
sions. Tools that assess quality of proteomic data based on
sound statistical principles are also needed. Such assessment
will allow us draw conclusions from proteomic studies, from
simple fold-changes to networks and models, with clearly
stated limitations in terms of statistical confidence.
In the current special issue, we selected several papers
with novel approaches which could result in improvement
in reproducibility of proteomics results. Topics covered
include improvements in quality assessment of tandem
mass spectrometry, combining search results to improve the
reliability of the predicted identities, and steps to improve
the reliability of MRM results. We hope these papers will
serve as examples to provide insights into how proteomic
analysis pipelines can be improved in the near future.
Quality assessment of tandem mass spectrometry has
been evaluated previously, but the methods have focused
primarily on supervised machine-learning approaches. The
limitations to these approaches are twofold: (1) they require
manually validated data to develop a classifier and (2) it is
difficult to create a classifier which is robust enough to
perform reasonably, given the inherently inconsistencies
observed when tandem mass spectrometers are utilized
under different conditions. Furthermore, the tandem mass
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spectra returning predicted protein identifications can be as
low as 10–20%. In an effort to resolve these issues, an
alternative approach for discriminating between poor
quality and high-quality spectra using an unsupervised
method, K-Means Clustering, is presented [2]. This method
can be trained to the specific data collected from an
experiment. The method reduced the database search time
by greater than 50% with a loss of potential identifications
between 2% and 14% in the dataset evaluated. Improving
the quality of the spectra submitted for identification serves
to reduce the time required to return the peptide identifica-
tion results as well as reduce the probability of a published
results relying on low-quality data.
Once a set of reasonable spectra have been selected for
analysis, protein identification is pursued. Both commercial
and freeware search engines are available for this task. Each
method provides a score and associated rank of the
predicted peptide sequence. Many also provide an estimate
of statistical significance. However, a direct comparison of
the predicted matches demonstrates that these methods can
present inconsistent results. Most of the search engines
agree on approximately 80% of the peptide identifications.
Unfortunately, the remaining predicted identifications vary
depending on the search engine used. As a result, effort has
been dedicated to improving the reliability of the results.
Statistical significance re-estimation, supervised machine
learning for scoring and prediction, and combining multiple
search engines’ results have been pursued. PepArML [3]
provides an underlying framework to combine each of these
improvements in a model-free, unsupervised manner.
In contrast with the unbiased methods utilized in the
discovery phase, which is characterized by analysis of
many proteins in few samples, the validation phase of
biomarker research focuses on measuring a few biomarkers
in many samples. Validation and quantitation in the clinical
environment traditionally is performed using immunoassay,
rather than the platform used during the discovery phase.
Unfortunately, immunoassay is a cumbersome tool when
tasked with measuring multiple proteins simultaneously.
Consequently, technical advances were pursued which
allowed for the discovery and validation to be performed
on the same technology. Multiple Reaction Monitoring
(MRM) has emerged as a sensitive approach for quantita-
tion of proteins [4]. The final contribution of this special
issue is focused on analysis of data collected through
targeted quantitative MS. Two significant contributions to
the field of MRM research are pursued: the optimization of
MRM-transition selection, and a novel scoring function
called Tcorr [5]. Unlike Scorr, which is a prominent method
utilizing spectrum information for database searching
algorithms in the analysis of tandem MS data, Tcorr uses a
small number of transition ions to predict peptide ID, thus
providing the possibility of improving the reliability of the
result.
While bioinformatics tools are necessary for the suc-
cessful completion of a study, they cannot substitute for
statistically and scientifically sound study and experimental
design. A confounding variable, once introduced, distorts
data irreparably. Post-collection analysis simply cannot
remove limitations introduced due to a lack of randomiza-
tion, replication, or avoidance of systematic bias. In this
special edition of Clinical Proteomics, we evaluated the
state of the art and advances in bioinformatics tools that
could be used to improve the reliability of proteomics
results collected from data utilizing good study design. We
are very grateful to the authors for their excellent
contributions, the reviewers for their timely evaluations,
and the Editor-in-Chief and staff of Clinical Proteomics for
the support provided throughout the construction of this
special issue.
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